A18.51
Tuberculous episcleritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Tuberculous episcleritis is an inflammation of the episclera, a thin layer of tissue covering the sclera of the eye, caused by tuberculosis bacteria. This condition is linked to a tuberculosis infection that has spread to ocular tissues. Recognizing the symptoms early and understanding its causes is essential for appropriate management, although diagnosis and treatment should always be guided by healthcare professionals.
Causes & Symptoms
Clinical Causes: Mycobacterium tuberculosis infection spreading to ocular tissues Reactivation of latent tuberculosis infection Dissemination from a primary TB site, such as the lungs Immune response to tuberculosis bacteria within ocular tissues
Key Symptoms: Redness and inflammation of the episclera Mild to moderate eye discomfort or pain Sensitivity to light Blurred vision or visual disturbances in some cases Swelling around the eye or eyelids
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a detailed medical history, eye examination, and laboratory tests. Eye doctors may perform slit-lamp exams to observe episcleral inflammation. Additional testing could include blood tests for tuberculosis, chest X-rays to identify pulmonary involvement, and sometimes tissue biopsies. Imaging studies help rule out other causes of ocular inflammation.
Treatment Protocols: Treatment primarily focuses on addressing the underlying tuberculosis infection, typically with anti-tubercular medications. Managing ocular inflammation may involve corticosteroid eye drops to reduce inflammation. Close monitoring is necessary to assess response to treatment and prevent complications. Collaboration between ophthalmologists and infectious disease specialists ensures comprehensive care.
Clinical Advice & FAQs
Billing Guidance
Is A18.51 a billable ICD-10 code?
Yes, A18.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A18.51?
Clinical documentation must specify the nature of Tuberculous episcleritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
